R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	AND Arg1:T1 Arg2:T3	
R3	Has_temporal Arg1:T1 Arg2:T4	
R4	AND Arg1:T5 Arg2:T6	
R5	multi Arg1:T12 Arg2:T9	
R6	AND Arg1:T10 Arg2:T9	
R7	Has_index Arg1:T16 Arg2:T17	
R8	Has_value Arg1:T14 Arg2:T15	
R9	Has_temporal Arg1:T14 Arg2:T16	
R10	Has_index Arg1:T10 Arg2:T11	
R11	Has_index Arg1:T10 Arg2:T12	
R12	AND Arg1:T5 Arg2:T7	
R13	AND Arg1:T9 Arg2:T11	
R14	AND Arg1:T9 Arg2:T12	
T1	Procedure 11 42	left atrial appendage occlusion
T2	Qualifier 0 10	successful
T3	Device 48 61	Amulet device
T4	Temporal 62 99	within 37 days prior to randomization
T5	Procedure 117 142	dual antiplatelet therapy
T6	Drug 144 155	clopidogrel
T7	Drug 160 180	acetylsalicylic acid
T9	Procedure 190 219	left atrial appendage closure
T10	Temporal 182 237	between left atrial appendage closure and randomization
T11	Reference_point 224 237	randomization
T12	Reference_point 190 219	left atrial appendage closure
T14	Person 253 256	age
T15	Value 257 274	18 years or older
T16	Temporal 275 323	at the time of signing the informed consent form
T17	Reference_point 290 323	signing the informed consent form
T18	Post-eligibility 325 507	participant is willing to follow all study procedures; especially randomized antiplatelet treatment regimen and follow-up visits with transesophageal echocardiography when applicable
T19	Informed_consent 509 571	participant is willing to sign the study informed consent form
